Bristol-Myers Squibb Co. BMY
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Bristol-Myers Squibb Co. (BMY) Core Market Data and Business Metrics
Latest Closing Price
$59.6Price-Earnings Ratio
-13.51Total Outstanding Shares
2.03 Billion SharesDividend
$0.62 Per Share QuarterlySIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
Route 206 And Province Line Road, Princeton, NJ, 08543
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 13,328,592 Shares | 2.78 | 3/14/2025 | 37,010,551 Shares |
| 11,957,015 Shares | 2.56 | 2/28/2025 | 30,571,531 Shares |
| 13,373,830 Shares | 1.91 | 2/14/2025 | 25,592,830 Shares |
| 10,097,959 Shares | 2.64 | 1/31/2025 | 26,695,018 Shares |
| 9,285,364 Shares | 2.96 | 1/15/2025 | 27,515,929 Shares |
| 13,055,161 Shares | 1.91 | 12/31/2024 | 24,932,099 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $-1.03 Billion |
| Net Cash Flow From Financing Activities, Continuing | $5.13 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-21.35 Billion |
| Net Cash Flow From Investing Activities | $-21.35 Billion |
| Exchange Gains/Losses | $-137 Million |
| Net Cash Flow | $-1.17 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Equity Method Investments | $44 Million |
| Income Tax Expense/Benefit, Deferred | $-2.09 Billion |
| Basic Average Shares | $2.03 Billion |
| Cost Of Revenue | $13.97 Billion |
| Gross Profit | $34.33 Billion |
| Benefits Costs and Expenses | $56.68 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-8.64 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $15 Million |
| Other Comprehensive Income/Loss | $308 Million |
| Comprehensive Income/Loss | $-8.63 Billion |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Intangible Assets | $23.31 Billion |
| Equity Attributable To Noncontrolling Interest | $53 Million |
| Other Current Assets | $16.48 Billion |
| Equity | $16.39 Billion |
| Liabilities | $76.22 Billion |
| Accounts Payable | $3.60 Billion |
Historical Dividends
Current dividend: $0.62 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Mar 3, 2025 | May 1, 2025 | Apr 4, 2025 | $0.62 | Quarterly |
| Dec 11, 2024 | Feb 3, 2025 | Jan 3, 2025 | $0.62 | Quarterly |
| Sep 10, 2024 | Nov 1, 2024 | Oct 4, 2024 | $0.6 | Quarterly |
| Jun 18, 2024 | Aug 1, 2024 | Jul 5, 2024 | $0.6 | Quarterly |
| Mar 1, 2024 | May 1, 2024 | Apr 5, 2024 | $0.6 | Quarterly |
| Dec 6, 2023 | Feb 1, 2024 | Jan 5, 2024 | $0.6 | Quarterly |